Premium

Small-cap technology companies often experience significant swings in investor sentiment, particularly during their early years as public companies. Metatek-Group Ltd. (TSX: MTEK) fits this profile perfectly. The company operates within a specialized segment of the technology sector, providing advanced geophysical solutions that support exploration …

Prosper Gold Corp. (TSXV: PGX) operates in one of the most speculative corners of the mining sector, where investor returns are often determined by exploration success rather than existing production. The company's share price remains near the lower end of its historical range, reflecting …

Nanalysis Scientific Corp. (TSXV: NSCI) occupies a unique position within Canada's small-cap market. Unlike many speculative companies that rely heavily on future concepts, Nanalysis has established products, commercial customers and recognized technology within the scientific-instrument sector. However, despite its technological strengths, the company's shares …

Manulife Financial Corporation (TSX: MFC) has undergone a notable transformation in how investors view the company. Once regarded primarily as a mature insurer offering dependable dividends and limited growth, the company is increasingly being recognized for its exposure to faster-growing international markets and expanding …

At the smallest end of the public equity market, investors often encounter companies whose shares trade at only fractions of a cent and whose fortunes can change dramatically with a single corporate update. NAVCO Pharmaceuticals Inc. (TSXV: NAV) is one such company. Operating within …

For investors willing to explore high-risk opportunities, Neural Therapeutics presents an intriguing proposition. The company is pursuing therapies derived from mescaline, a naturally occurring psychedelic compound, while also working to establish a sustainable source of supply. However, like many early-stage biotechnology companies, it remains …

Vector Science and Therapeutics (TSXV: PAIN) has quickly emerged as one of the more talked-about healthcare stocks on the Canadian small-cap market. Since entering the public markets in 2026, the company has generated interest through a combination of innovative healthcare technologies and notable share-price …